Archive for April 2023

The approval of Seres’ microbiome drug took 12 years. Here’s a timeline of major milestones and setbacks along the way. Read More

Significantly more graduates of public colleges and universities in Massachusetts stay and work in our state than graduates of private schools. Read More

Middlesex Savings Bank has named Dana Neshe as its new CEO, and will start in April 2024. This new appointment will make the Natick-based bank the largest Mass.-based bank to have a female CEO. Read More

The FDA gave the treatment for recurrent Clostridioides difficile infection the green light nearly 10 years after the drug was first tested in humans. Read More

Just under three months after it laid off nearly half its staff, a Flagship Pioneering spinout is making cuts again. Read More

First Republic “needs to pull off the mother of all pivots to survive,” an analyst said. Read More

A 200,000-square-foot lab project is being pursued in the heart of Union Square. Read More

“The banking industry is resilient, the consumer is still strong, and banks are well-capitalized,” said Santander US CEO Tim Wennes at an event in Providence, Rhode Island. Read More

Both the House and Healey’s budget proposals for next year include spending intended to boost workforce development in the state’s life sciences sector. Read More

Gov. Maura Healey is set to reauthorize the state’s Life Sciences Initiative, paving the way for a third iteration of a multimillion-dollar spending bill to incentivize the growth of the state’s biopharmaceutical industry. Read More